Kurtais Yesim, Kutlay Sehim, Ergin Süreyya
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Ankara University, 06530 Ankara, Turkey.
Curr Pharm Des. 2006;12(1):37-45.
Fibromyalgia syndrome is a nonarticular rheumatic disorder characterised by diffuse musculoskeletal pain, stiffness, fatigue, disturbed sleep and tender points. The pathophysiology is not well understood and treatment remains a challenge. Although pharmacological therapy is still the primary treatment choice, a long-term effective intervention has not been demonstrated yet. Thus, besides pharmacotherapy, other multimodal interventions are often used. Exercise and cognitive-behavioural treatments which exist in the multimodal approach and encompass largely self-managed strategy, are reviewed in this article. Although, there is a great number of exercise studies, the large diversity of outcome measures and measurement instruments that have been used in studies, varying intensity and types of exercises, small sample sizes, high attrition rates, large variability in baseline function, symptom severity and psychosocial status limit to come to a conclusion about the efficacy of exercise in the treatment of fibromyalgia syndrome. There are also inconclusive results about the efficacy of cognitive-behavioural treatment because of limited number of studies with small sample sizes of patients with fibromyalgia syndrome. However, the results of the trials overall demonstrate the beneficial effects of both different types of exercise and cognitive-behavioural treatment, on the other hand, there is still a need for larger, more systematic and randomised controlled trials to evaluate the effectiveness.
纤维肌痛综合征是一种非关节性风湿性疾病,其特征为弥漫性肌肉骨骼疼痛、僵硬、疲劳、睡眠障碍和压痛点。其病理生理学尚未完全明确,治疗仍然是一项挑战。尽管药物治疗仍是主要的治疗选择,但尚未证明有长期有效的干预措施。因此,除药物治疗外,还经常使用其他多模式干预措施。本文综述了多模式方法中存在的运动和认知行为治疗,这些治疗主要包括自我管理策略。尽管有大量关于运动的研究,但研究中使用的结果测量和测量工具种类繁多,运动强度和类型各异,样本量小,损耗率高,基线功能、症状严重程度和社会心理状态差异大,这限制了我们就运动治疗纤维肌痛综合征的疗效得出结论。由于针对纤维肌痛综合征患者的研究数量有限且样本量小,认知行为治疗的疗效也尚无定论。然而,试验结果总体上证明了不同类型的运动和认知行为治疗的有益效果,另一方面,仍需要更大规模、更系统的随机对照试验来评估其有效性。